Suppr超能文献

单克隆抗体ALK1可识别一种与2p23/ALK重排相关的间变性大细胞淋巴瘤的独特形态学亚型。

The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements.

作者信息

Pittaluga S, Wlodarska I, Pulford K, Campo E, Morris S W, Van den Berghe H, De Wolf-Peeters C

机构信息

Department of Pathology, University of Leuven, Belgium.

出版信息

Am J Pathol. 1997 Aug;151(2):343-51.

Abstract

Anaplastic large cell lymphoma (ALCL) is a heterogeneous group of diseases by morphology, phenotype, genotype, and clinical presentation. Using a new monoclonal antibody (ALK1) that recognizes the native anaplastic lymphoma kinase (ALK) protein as well as the fusion product of the t(2;5)(p23;q35), nucleophosmin (NPM)/ALK, we investigated for ALK expression cases diagnosed as ALCL as well as lympho-proliferative disorders possessing overlapping features with ALCL. Thirteen cases showed cytoplasmic staining of the neoplastic cells. These cases were characterized by a fairly uniform morphology and occurred in children and young adults as a systemic disease. All other cases comprising T or null ALCL (17 cases), B ALCL (8 cases), Hodgkin's disease (HD) (15 cases), HD-like ALCL (23 cases), and lymphomatoid papulosis (9 cases), were negative for ALK expression. Translocation t(2;5)(p23;q35) was found by classical cytogenetics or interphase fluorescence in situ hybridization in 8 of the ALK1-positive cases and by reverse transcription-polymerase chain reaction in 1 other case. Two additional ALK1-positive cases with an abnormal karyotype, but without t(2;5)(p23;q35), showed by fluorescence in situ hybridization analysis a cryptic NPM/ALK gene fusion caused by an insertion of ALK near NPM in one case and a translocation of ALK to 2q35 as a result of an indiscernible inv(2)(p23q35) in the other. The latter variant translocation points to a localization of an unknown gene at 2q35 that, like NPM, might deregulate ALK and be involved in the pathogenesis of ALCL. In summary, immunohistochemistry with ALK1 antibody allows the identification of a distinct subgroup within the ALCL of T or null phenotype that is associated with 2p23 abnormalities and lacks the marked histological pleomorphism described in ALCL in general. Whereas immunostaining is the most sensitive method to identify this group, it does not help to additionally clarify the relationship among ALCL, HD, and HD-like ALCL.

摘要

间变性大细胞淋巴瘤(ALCL)在形态学、表型、基因型和临床表现方面是一组异质性疾病。我们使用一种新的单克隆抗体(ALK1)来研究诊断为ALCL以及与ALCL具有重叠特征的淋巴增殖性疾病的病例中ALK的表达情况,该抗体可识别天然间变性淋巴瘤激酶(ALK)蛋白以及t(2;5)(p23;q35)的融合产物核仁磷酸蛋白(NPM)/ALK。13例病例显示肿瘤细胞胞质染色。这些病例具有相当一致的形态学特征,发生于儿童和年轻人,表现为全身性疾病。所有其他病例,包括T或无表型的ALCL(17例)、B型ALCL(8例)、霍奇金病(HD)(15例)、HD样ALCL(23例)和淋巴瘤样丘疹病(9例),ALK表达均为阴性。在8例ALK1阳性病例中通过经典细胞遗传学或间期荧光原位杂交发现了t(2;5)(p23;q35)易位,在另外1例病例中通过逆转录-聚合酶链反应发现。另外2例ALK1阳性病例核型异常,但无t(2;5)(p23;q35),荧光原位杂交分析显示,1例病例中由于ALK插入NPM附近导致隐匿性NPM/ALK基因融合,另1例病例中由于难以识别的inv(2)(p23q35)导致ALK易位至2q35。后一种变异易位表明2q35存在一个未知基因,该基因可能与NPM一样使ALK失调,并参与ALCL的发病机制。总之,使用ALK1抗体进行免疫组织化学可在T或无表型的ALCL中识别出一个独特的亚组,该亚组与2p23异常相关,且缺乏一般ALCL中所描述的明显组织学多形性。虽然免疫染色是识别该组的最敏感方法,但它无助于进一步阐明ALCL、HD和HD样ALCL之间的关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b700/1858018/7544c827d32a/amjpathol00020-0037-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验